Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Peritoneal Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: Peritoneal Cancer
USOR Number: 19046

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: Peritoneal Cancer
USOR Number: 19046

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: Peritoneal Cancer
USOR Number: 19046

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: Endometrial Cancer
USOR Number: 19034

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: Endometrial Cancer
USOR Number: 19034

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: Endometrial Cancer
USOR Number: 19034

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Arizona Oncology - Tucson

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: Urothelial Cancer
USOR Number: 19032

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Arizona Oncology - Tucson

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: Urothelial Cancer
USOR Number: 19032

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Arizona Oncology - Tucson

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: Urothelial Cancer
USOR Number: 19032

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Myelomas

Clinical Trial at: Arizona Oncology - Tucson

A Randomized Open-Label Phase 1/2 Study of INCB001158Combined With Subcutaneous (SC) Daratumumab, Compared toDaratumumab SC, in Participants With Relapsed or RefractoryMultiple Myeloma (INCB 01158-206)

  • Details

ClinicalTrials.gov ID: NCT03837509
Diagnosis Type: Myelomas
USOR Number: 19021

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page
1 2 3 4 5 6 … 13

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.